Side-by-side comparison: effects, dosing ranges, side effects, regulatory status, and reconstitution.
Peptide A
Longevity
Synthetic pineal tetrapeptide that activates telomerase and modulates melatonin production.
Peptide B
Longevity
Central cellular cofactor — supplemented to support mitochondrial function and sirtuin activity.
Typical vial
10 mg
Typical dose
5000-10000 mcg
Half-life
~30 minutes (short half-life but biological effects persist due to gene expression changes)
FDA status
Not FDA approved for human use. No clinical trials submitted…
Typical vial
500 mg
Typical dose
50-200 mg (SubQ); 500-1500 mg (IV) mcg
Half-life
~6-10 hours (cellular turnover)
FDA status
Not FDA approved as a therapeutic. Available via compounding…
Epithalon effects
NAD+ (Injectable) effects
Epithalon side effects
NAD+ (Injectable) side effects
Epithalon dosing ranges
Anti-aging and telomere support
5-10 mg · Once daily (SubQ) · 10-20 days, repeated 1-2 times per year
NAD+ (Injectable) dosing ranges
IV anti-aging clinic protocol
500-1500 mg · Per infusion, weekly to monthly · Cycle-based
Subcutaneous wellness
50-200 mg · Daily or alternate-day · 2-4 week cycles
Intranasal
20-100 mg · Daily · Cycle-based
Epithalon: Synthetic pineal tetrapeptide that activates telomerase and modulates melatonin production. Typical dose 5000-10000 mcg. NAD+ (Injectable): Central cellular cofactor — supplemented to support mitochondrial function and sirtuin activity. Typical dose 50-200 mg (SubQ); 500-1500 mg (IV) mcg. Both fall under the Longevity category.
Stacking Epithalon with NAD+ (Injectable) is a protocol-design question best raised with a clinician — it depends on your goal, current bloodwork, and whether both peptides target overlapping mechanisms. Both peptides should be tracked independently with separate injection sites and timing. PinnyPeptide supports multi-peptide stacks with automatic injection site rotation.
Epithalon is typically dosed: Once daily (SubQ) for Anti-aging and telomere support. NAD+ (Injectable) is typically dosed: Per infusion, weekly to monthly for IV anti-aging clinic protocol; Daily or alternate-day for Subcutaneous wellness; Daily for Intranasal.
Epithalon: Not FDA approved for human use. No clinical trials submitted to the FDA. NAD+ (Injectable): Not FDA approved as a therapeutic. Available via compounding pharmacies for off-label use. NAD+ precursors (NR as Niagen, NMN) sold as dietary supplements.
Log doses, automate injection site rotation, and never lose track of where you last pinned. Free forever.
Get Started Free